Anhui Fengyuan Pharmaceutical Co., Ltd.

¥5.34As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000153Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.56%)
Div yield 1.87%
ROE 3.72%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.55
PE TTM 29.24
TSR TTM (18.17%)
Mkt cap ¥2.481B
ROIC 3.25%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.53
22.26%
(72.79%)
Hold 4|7|9|6|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.06
0.06
0.06
18.90%
17.34%
10.35%
(5.45%)
Revenue¥M
266.2
267.3
269.3
272.6
5.90%
3.03%
4.49%
3.21%
Peers (US$372.0M)
Cap (US$)
PE
349.0M
31.54x
365.3M
11.06x
Capital
TTM
5Y
10Y
Leveragex
0.901
(0.046)
(0.037)
EBIT/Intx
0.600
0.420
0.361
Own earn%
(62.50)
(0.08)
2.34
Sh yield%
26.97
32.62
33.16
Owners
Insiders/Inst%
0.47
66.01
Short interest%
1.21
SBC / revenue%
0.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–9
$1 testx
1.8
Incr. ROIC%
44